Neurodegenerative Drugs

Global Market Trajectory & Analytics

MCP-6313

EXECUTIVE ENGAGEMENTS

OUTREACH

8719
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1221
Interactions with Platform & by Email

PARTICIPANTS

262
Unique # Participated

VALIDATIONS

118
Responses Validated*

COMPETITORS

165
Responses Validated*

BRANDS

0
Responses Validated*
* Login for a full stack data experience

DATE

JUL 2020

TABLES

117

PAGES

312

EDITION

17

PRICE

USD $5450


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Neurodegenerative Drugs estimated at US$34.3 Billion in the year 2020, is projected to reach a revised size of US$47.8 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. Parkinsons Disease, one of the segments analyzed in the report, is projected to record a 5.6% CAGR and reach US$15.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Huntington Disease segment is readjusted to a revised 4.1% CAGR for the next 7-year period.
The Neurodegenerative Drugs market in the U.S. is estimated at US$9.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.8 Billion by the year 2027 trailing a CAGR of 7.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.
In the global Amyotrophic Lateral Sclerosis segment, USA, Canada, Japan, China and Europe will drive the 4.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.1 Billion in the year 2020 will reach a projected size of US$6.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$6.4 Billion by the year 2027, while Latin America will expand at a 5.5% CAGR through the analysis period. We bring years of research experience to this 17th edition of our report. The 312-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

SELECT PLAYERS

Biogen, Inc.; Boehringer Ingelheim GmbH; Daiichi Sankyo Co., Ltd.; Eisai Co., Ltd.; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; H. Lundbeck A/S; Merck KGaA; Mitsubishi Tanabe Pharma Corporation; Novartis International AG; Pfizer, Inc.; Reata Pharmaceuticals, Inc.; Sage Therapeutics, Inc.; Sanofi; Teva Pharmaceutical Industries Ltd.; UCB SA

SEGMENTS

» Indication Drug (Parkinsons Disease, Huntington Disease, Amyotrophic Lateral Sclerosis, Alzheimers Disease, and Other Indication Drugs)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Global Competitor Market Shares
Neurodegenerative Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Neurodegenerative Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Neurodegenerative Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
Neurodegenerative Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
Parkinsons Disease (Indication Drug) World Market by Region/Country in US$ Million: 2018 to 2025
Parkinsons Disease (Indication Drug) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Parkinsons Disease (Indication Drug) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Huntington Disease (Indication Drug) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
Huntington Disease (Indication Drug) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
Huntington Disease (Indication Drug) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Amyotrophic Lateral Sclerosis (Indication Drug) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
Amyotrophic Lateral Sclerosis (Indication Drug) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
Amyotrophic Lateral Sclerosis (Indication Drug) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
Alzheimers Disease (Indication Drug) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
Alzheimers Disease (Indication Drug) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
Alzheimers Disease (Indication Drug) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
Other Indication Drugs (Indication Drug) World Market by Region/Country in US$ Million: 2018 to 2025
Other Indication Drugs (Indication Drug) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Other Indication Drugs (Indication Drug) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
GEOGRAPHIC MARKET ANALYSIS
United States
Market Facts & Figures
US Neurodegenerative Drugs Market Share (in %) by Company: 2019 & 2025
United States Neurodegenerative Drugs Market Estimates and Projections in US$ Million by Indication Drug: 2018 to 2025
Neurodegenerative Drugs Market in the United States by Indication Drug: A Historic Review in US$ Million for 2009-2017
United States Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025
Canada
Canadian Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018 to 2025
Canadian Neurodegenerative Drugs Historic Market Review by Indication Drug in US$ Million: 2009-2017
Neurodegenerative Drugs Market in Canada: Percentage Share Breakdown of Sales by Indication Drug for 2009, 2019, and 2025
Japan
Japanese Market for Neurodegenerative Drugs: Annual Sales Estimates and Projections in US$ Million by Indication Drug for the Period 2018-2025
Neurodegenerative Drugs Market in Japan: Historic Sales Analysis in US$ Million by Indication Drug for the Period 2009-2017
Japanese Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025
China
Chinese Neurodegenerative Drugs Market Growth Prospects in US$ Million by Indication Drug for the Period 2018-2025
Neurodegenerative Drugs Historic Market Analysis in China in US$ Million by Indication Drug: 2009-2017
Chinese Neurodegenerative Drugs Market by Indication Drug: Percentage Breakdown of Sales for 2009, 2019, and 2025
Europe
Market Facts & Figures
European Neurodegenerative Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European Neurodegenerative Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025
Neurodegenerative Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
European Neurodegenerative Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
European Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018-2025
Neurodegenerative Drugs Market in Europe in US$ Million by Indication Drug: A Historic Review for the Period 2009-2017
European Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025
France
Neurodegenerative Drugs Market in France by Indication Drug: Estimates and Projections in US$ Million for the Period 2018-2025
French Neurodegenerative Drugs Historic Market Scenario in US$ Million by Indication Drug: 2009-2017
French Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025
Germany
Neurodegenerative Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Indication Drug for the Period 2018-2025
German Neurodegenerative Drugs Historic Market Analysis in US$ Million by Indication Drug: 2009-2017
German Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025
Italy
Italian Neurodegenerative Drugs Market Growth Prospects in US$ Million by Indication Drug for the Period 2018-2025
Neurodegenerative Drugs Historic Market Analysis in Italy in US$ Million by Indication Drug: 2009-2017
Italian Neurodegenerative Drugs Market by Indication Drug: Percentage Breakdown of Sales for 2009, 2019, and 2025
United Kingdom
United Kingdom Market for Neurodegenerative Drugs: Annual Sales Estimates and Projections in US$ Million by Indication Drug for the Period 2018-2025
Neurodegenerative Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Indication Drug for the Period 2009-2017
United Kingdom Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025
Spain
Spanish Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018 to 2025
Spanish Neurodegenerative Drugs Historic Market Review by Indication Drug in US$ Million: 2009-2017
Neurodegenerative Drugs Market in Spain: Percentage Share Breakdown of Sales by Indication Drug for 2009, 2019, and 2025
Russia
Russian Neurodegenerative Drugs Market Estimates and Projections in US$ Million by Indication Drug: 2018 to 2025
Neurodegenerative Drugs Market in Russia by Indication Drug: A Historic Review in US$ Million for 2009-2017
Russian Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025
Rest of Europe
Rest of Europe Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018-2025
Neurodegenerative Drugs Market in Rest of Europe in US$ Million by Indication Drug: A Historic Review for the Period 2009-2017
Rest of Europe Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025
Asia-Pacific
Asia-Pacific Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Neurodegenerative Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
Asia-Pacific Neurodegenerative Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
Neurodegenerative Drugs Market in Asia-Pacific by Indication Drug: Estimates and Projections in US$ Million for the Period 2018-2025
Asia-Pacific Neurodegenerative Drugs Historic Market Scenario in US$ Million by Indication Drug: 2009-2017
Asia-Pacific Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025
Australia
Neurodegenerative Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Indication Drug for the Period 2018-2025
Australian Neurodegenerative Drugs Historic Market Analysis in US$ Million by Indication Drug: 2009-2017
Australian Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025
India
Indian Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018 to 2025
Indian Neurodegenerative Drugs Historic Market Review by Indication Drug in US$ Million: 2009-2017
Neurodegenerative Drugs Market in India: Percentage Share Breakdown of Sales by Indication Drug for 2009, 2019, and 2025
South Korea
Neurodegenerative Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Indication Drug for the Period 2018-2025
South Korean Neurodegenerative Drugs Historic Market Analysis in US$ Million by Indication Drug: 2009-2017
Neurodegenerative Drugs Market Share Distribution in South Korea by Indication Drug: 2009 VS 2019 VS 2025
Rest of Asia-Pacific
Rest of Asia-Pacific Market for Neurodegenerative Drugs: Annual Sales Estimates and Projections in US$ Million by Indication Drug for the Period 2018-2025
Neurodegenerative Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Indication Drug for the Period 2009-2017
Rest of Asia-Pacific Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025
Latin America
Latin American Neurodegenerative Drugs Market Trends by Region/Country in US$ Million: 2018-2025
Neurodegenerative Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
Latin American Neurodegenerative Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Latin American Neurodegenerative Drugs Market Growth Prospects in US$ Million by Indication Drug for the Period 2018-2025
Neurodegenerative Drugs Historic Market Analysis in Latin America in US$ Million by Indication Drug: 2009-2017
Latin American Neurodegenerative Drugs Market by Indication Drug: Percentage Breakdown of Sales for 2009, 2019, and 2025
Argentina
Argentinean Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018-2025
Neurodegenerative Drugs Market in Argentina in US$ Million by Indication Drug: A Historic Review for the Period 2009-2017
Argentinean Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025
Brazil
Neurodegenerative Drugs Market in Brazil by Indication Drug: Estimates and Projections in US$ Million for the Period 2018-2025
Brazilian Neurodegenerative Drugs Historic Market Scenario in US$ Million by Indication Drug: 2009-2017
Brazilian Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025
Mexico
Neurodegenerative Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Indication Drug for the Period 2018-2025
Mexican Neurodegenerative Drugs Historic Market Analysis in US$ Million by Indication Drug: 2009-2017
Mexican Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025
Rest of Latin America
Rest of Latin America Neurodegenerative Drugs Market Estimates and Projections in US$ Million by Indication Drug: 2018 to 2025
Neurodegenerative Drugs Market in Rest of Latin America by Indication Drug: A Historic Review in US$ Million for 2009-2017
Rest of Latin America Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025
Middle East
The Middle East Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Neurodegenerative Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017
The Middle East Neurodegenerative Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025
The Middle East Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018 to 2025
The Middle East Neurodegenerative Drugs Historic Market by Indication Drug in US$ Million: 2009-2017
Neurodegenerative Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Indication Drug for 2009, 2019, and 2025
Iran
Iranian Market for Neurodegenerative Drugs: Annual Sales Estimates and Projections in US$ Million by Indication Drug for the Period 2018-2025
Neurodegenerative Drugs Market in Iran: Historic Sales Analysis in US$ Million by Indication Drug for the Period 2009-2017
Iranian Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025
Israel
Israeli Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018-2025
Neurodegenerative Drugs Market in Israel in US$ Million by Indication Drug: A Historic Review for the Period 2009-2017
Israeli Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025
Saudi Arabia
Saudi Arabian Neurodegenerative Drugs Market Growth Prospects in US$ Million by Indication Drug for the Period 2018-2025
Neurodegenerative Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Indication Drug: 2009-2017
Saudi Arabian Neurodegenerative Drugs Market by Indication Drug: Percentage Breakdown of Sales for 2009, 2019, and 2025
United Arab Emirates
Neurodegenerative Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Indication Drug for the Period 2018-2025
United Arab Emirates Neurodegenerative Drugs Historic Market Analysis in US$ Million by Indication Drug: 2009-2017
Neurodegenerative Drugs Market Share Distribution in United Arab Emirates by Indication Drug: 2009 VS 2019 VS 2025
Rest of Middle East
Neurodegenerative Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Indication Drug for the Period 2018-2025
Rest of Middle East Neurodegenerative Drugs Historic Market Analysis in US$ Million by Indication Drug: 2009-2017
Rest of Middle East Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025
Africa
African Neurodegenerative Drugs Market Estimates and Projections in US$ Million by Indication Drug: 2018 to 2025
Neurodegenerative Drugs Market in Africa by Indication Drug: A Historic Review in US$ Million for 2009-2017
African Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025
Total Companies Profiled: 165

General queries: Info411@StrategyR.com